[PHARMA] QoQ Annualized Quarter Result on 31-Mar-2023 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
18-May-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
31-Mar-2023 [#1]
Profit Trend
QoQ- 101.74%
YoY- -90.45%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 3,404,481 3,486,232 3,458,376 3,521,816 3,510,677 3,530,609 3,446,552 -0.81%
PBT -62,823 -54,298 31,070 36,772 -580,846 76,732 83,920 -
Tax -13,213 -4,310 -20,890 -25,708 -24,204 -24,536 -24,380 -33.45%
NP -76,036 -58,609 10,180 11,064 -605,050 52,196 59,540 -
-
NP to SH -77,452 -59,641 9,216 10,592 -607,317 49,430 56,912 -
-
Tax Rate - - 67.24% 69.91% - 31.98% 29.05% -
Total Cost 3,480,517 3,544,841 3,448,196 3,510,752 4,115,727 3,478,413 3,387,012 1.82%
-
Net Worth -281,734 -245,740 -137,571 -142,812 -248,894 411,327 406,087 -
Dividend
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Div - - - - 24,889 33,185 34,058 -
Div Payout % - - - - 0.00% 67.14% 59.84% -
Equity
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Net Worth -281,734 -245,740 -137,571 -142,812 -248,894 411,327 406,087 -
NOSH 1,441,229 1,441,229 1,310,208 1,310,208 1,309,126 1,309,126 1,309,126 6.60%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -2.23% -1.68% 0.29% 0.31% -17.23% 1.48% 1.73% -
ROE 0.00% 0.00% 0.00% 0.00% 0.00% 12.02% 14.01% -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
RPS 248.93 259.62 263.96 268.80 268.00 269.52 263.10 -3.61%
EPS -5.66 -4.44 0.70 0.80 -46.36 3.77 4.34 -
DPS 0.00 0.00 0.00 0.00 1.90 2.53 2.60 -
NAPS -0.206 -0.183 -0.105 -0.109 -0.19 0.314 0.31 -
Adjusted Per Share Value based on latest NOSH - 1,310,208
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
RPS 236.22 241.89 239.96 244.36 243.59 244.97 239.14 -0.81%
EPS -5.37 -4.14 0.64 0.73 -42.14 3.43 3.95 -
DPS 0.00 0.00 0.00 0.00 1.73 2.30 2.36 -
NAPS -0.1955 -0.1705 -0.0955 -0.0991 -0.1727 0.2854 0.2818 -
Price Multiplier on Financial Quarter End Date
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Date 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 -
Price 0.385 0.435 0.37 0.285 0.545 0.515 0.595 -
P/RPS 0.15 0.17 0.14 0.11 0.20 0.19 0.23 -24.73%
P/EPS -6.80 -9.79 52.60 35.25 -1.18 13.65 13.70 -
EY -14.71 -10.21 1.90 2.84 -85.07 7.33 7.30 -
DY 0.00 0.00 0.00 0.00 3.49 4.92 4.37 -
P/NAPS 0.00 0.00 0.00 0.00 0.00 1.64 1.92 -
Price Multiplier on Announcement Date
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Date 29/02/24 29/11/23 11/08/23 18/05/23 27/02/23 24/11/22 19/08/22 -
Price 0.37 0.405 0.42 0.38 0.44 0.55 0.595 -
P/RPS 0.15 0.16 0.16 0.14 0.16 0.20 0.23 -24.73%
P/EPS -6.53 -9.12 59.71 47.01 -0.95 14.58 13.70 -
EY -15.31 -10.97 1.67 2.13 -105.37 6.86 7.30 -
DY 0.00 0.00 0.00 0.00 4.32 4.61 4.37 -
P/NAPS 0.00 0.00 0.00 0.00 0.00 1.75 1.92 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment